A previous meta-analysis comprising nine studies on HIF1A and clinicopathological features in GC10 reported that positive HIF1A protein level was associated with TNM stage progression, differentiated GC cell status, T stage progression, vascular invasion, and lymph node metastasis. Here, HIF1A is linked to gastric cancer.